Accellacare
- Company typePrivate
- Founded2020
- HeadquartersWinston Salem, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
Accellacare firmographics
Firmographics- Name
- Accellacare
- Legal name
- Accellacare
- Website
- https://accellacare.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Ownership category
- akta.pro rank
Accellacare industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Ambulatory Health Care Services (621), Health Care and Social Assistance (62)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industry
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where Accellacare is headquartered
LocationHeadquarters
- HQ city
- Winston Salem
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Accellacare business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Site Network Services: Providing pharmaceutical companies and CROs access to a global network of clinical research sites for patient recruitment and trial execution. Revenue is generated through contracted service fees for site participation, patient enrollment, and study conduct.
- In-Home Clinical Services: Bringing clinical trial visits directly to patients at home through a network of licensed healthcare professionals. Services include study drug administration, sample collection, patient assessments, and monitoring across 60+ countries.
- Site Resourcing: Providing qualified clinical research staffing support to sites with temporary capacity needs. Services include placement of clinical research nurses, coordinators, and other clinical research professionals across 60+ countries with a database of 77k+ candidates.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Accellacare product offering
Product offeringCore offering
Accellacare is a global clinical research network that provides patient-centric solutions to pharmaceutical, biotechnology, and medical device sponsors. Its portfolio consists of four integrated offerings: Accellacare Site Network (50+ owned and affiliate research sites across the US, UK, Spain, and India), Accellacare In-Home Services (decentralized home-based trial visits across 60+ countries), Accellacare Site Resourcing (staffing support with access to 77k+ candidates), and Patient Voice (patient engagement program).
Product overview
Accellacare is ICON plc's global clinical research network providing a patient-centric approach to clinical trials. The portfolio consists of four integrated solutions: Accellacare Site Network (the core platform with 50+ research sites across 4 countries enabling faster study start-up and patient recruitment), Accellacare In-Home Services (a complementary service bringing trial visits directly to patients' homes across 60+ countries), Accellacare Site Resourcing (a staffing module providing clinical research professionals to fill site capacity gaps), and Patient Voice (an engagement program that leverages patient insights to improve feasibility, recruitment, and retention strategies). The solutions work together to deliver integrated, decentralised trial options with higher recruitment and retention rates.
Differentiator
Problem solved
Functional benefit
Brands
- Accellacare Site Network: Global clinical research site network offering feasibility, central process management, and patient engagement to accelerate study start-up and recruitment.
- Accellacare In-Home Services
- Accellacare Site Resourcing
- Accellacare Patient Voice
Products and services
- Accellacare Site Network A global clinical research network with 50+ owned and affiliate sites spanning the US, UK, Spain, and India, offering feasibility, central process management, and a dedicated patient engagement team to accelerate study start-up and drive patient identification and recruitment for pharmaceutical and biotech sponsors.
- Accellacare In-Home Services A full suite of home trial services bringing clinical trial visits directly to patients wherever they live, study, work or travel, conducted by skilled mobile healthcare professionals (Registered Nurses, Licensed Practical Nurses, Phlebotomists) across 60+ countries on six continents, offered stand-alone or as part of integrated ICON decentralized trial solutions.
- Accellacare Site Resourcing Staffing support service providing skilled, experienced and trained clinical research professionals including clinical research nurses, coordinators, trial educators, and site managers, with access to 77k+ highly qualified candidates across 60+ countries to fill staffing gaps for research-naive sites or sites needing additional capacity.
- Patient Voice A patient engagement program that engages directly with patients, care partners, healthcare providers and patient advocacy groups to uncover insights that drive protocol-specific support solutions and improve feasibility, recruitment, and retention strategies across clinical studies.
Quantifiable outcome
- 40% higher patient recruitment per site vs industry benchmarks
- +4 more outcomes
Companies that use Accellacare
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Accellacare technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Accellacare partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core.
- Asclepes ResearchcorePartnership with Asclepes Research Centers in the United States, bringing specialized expertise in psychiatry and CNS research across adult, geriatric, and pediatric populations. Asclepes operates phase I-IV clinical pharmacology units and brings oncology and internal medicine sites to the network.
- Olympian Clinical ResearchcorePartnership with Olympian Clinical Research in Tampa, FL, founded by Dr. Panos Vasiloudes. Specializes in dermatology, CNS, and aesthetic clinical research with experience in over 100 phase I-IV trials in adult and pediatric patients.
- Curiositas ad SanumcorePartnership with Curiositas ad Sanum in Munich and Haag, Germany. Conducts national and international studies in phases II-IV and sees over 500 patients with neurological diseases annually.
- IntermedcorePartnership with Intermed (Institute for Medical Research and Drug Safety) in Germany, focused on CNS, pain, and pulmonology. Completed around 100 studies and has been designated 'top recruiter' multiple times.
- QuironsaludcorePartnership with Quirónsalud, the leading hospital group in Spain (part of Fresenius-Helios, Europe's largest hospital family). Operates 125+ health centers with 54 hospital facilities totaling 8,000 beds across Spain, Latin America.
- KO-MED Clinical CenterscorePartnership with KO-MED Clinical Centers, a network of 11 clinical trial sites in Poland specializing in oncology, cardiology, diabetology, allergology, rheumatology, vaccines research. Repeatedly received 'top recruiter' status.
- Symphony Clinical ResearchcoreSymphony Clinical Research, the leading global provider of at-home care and nursing for clinical trials owned by ICON, provides integrated operations for in-home patient assessments as part of decentralized trials with Accellacare.
- PMG ResearchcorePMG Research, previously acquired by ICON, became part of the Accellacare Site Network launch in September 2020, contributing US-based research sites to the network.
- MeDiNova ResearchcoreMeDiNova Research, previously acquired by ICON, became part of the Accellacare Site Network launch in September 2020, contributing EMEA-based research sites to the network.
- Brian Moran Cancer Institute at Duly Health and CarecorePartnership with Brian Moran Cancer Institute at Duly Health and Care in Illinois, expanding Accellacare's oncology research capabilities within the site network.
Scale indicators15 records
Recent moves8 records
Expansion highlights5 records
Accellacare competitors and assessment
Company assessmentDirect peers
- PPD (Thermo Fisher Scientific): PPD, the clinical research services arm of Thermo Fisher Scientific, operates a global CRO with site networks, patient recruitment, and decentralized trial capabilities. It is one of the closest competitors to Accellacare in site network scale and sponsor relationships.
- Fortrea (formerly Labcorp Drug Development): Fortrea is a global CRO spun out of Labcorp that operates site networks and patient recruitment services comparable to Accellacare. It serves similar pharma and biotech sponsors with end-to-end clinical research services, including decentralized trial support.
- Parexel International: Parexel is a top-tier global CRO with dedicated site networks and patient recruitment solutions comparable to Accellacare's offerings. It serves similar large pharma and biotech sponsors with Phase I-IV clinical development and DCT services.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO offering Phase I-IV clinical development services with site networks comparable in scale to Accellacare. It targets similar therapeutic areas (CNS, cardiovascular, oncology) and biotech/pharma sponsors.
- Medpace: Medpace is a mid-to-large CRO with a network of clinical research sites and full-service trial management. It competes with Accellacare for biotech and mid-size pharma sponsors with comparable Phase II-IV clinical research services and site activation capabilities.
- Syneos Health: Syneos Health operates a global clinical research site network combined with commercial services, directly comparable to Accellacare's Site Network and patient recruitment model. It targets the same large pharma and biotech customers with integrated clinical and post-approval offerings.
Emerging players
- ObvioHealth: ObvioHealth is a digital DCT provider offering decentralized and hybrid clinical trial services with remote patient monitoring and home-based visits. It competes with Accellacare's In-Home Services arm for sponsors seeking decentralized trial execution.
- Science 37: Science 37 is a DCT-focused clinical research company specializing in fully decentralized, patient-centric trial models. It overlaps with Accellacare's In-Home Services and decentralized trial positioning, serving as an emerging pure-play competitor in the DCT niche.
- Celerion: Celerion is a CRO specializing in early-phase clinical research, including clinical pharmacology and Phase I studies. It overlaps with Accellacare's early-phase site network activities and shares a focus on patient recruitment and specialized clinical capabilities.
Broad incumbents
- IQVIA: IQVIA is the world's largest CRO with extensive site networks, DCT capabilities, and technology platforms. It is a broad incumbent operating across the full clinical research value chain that directly competes with Accellacare's Site Network, In-Home Services, and patient recruitment offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Accellacare social profiles
Digital presenceAccellacare compliance and trust
Trust signalCompliance2 records
Accellacare financial estimates
Financial estimateRevenue estimate
Valuation estimate
Accellacare leadership team
Management profileNumber of profiles
Profiles7 records
Accellacare funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Accellacare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Accellacare
What does Accellacare do?
Accellacare is a global clinical research network that provides patient-centric solutions to pharmaceutical, biotechnology, and medical device sponsors. Its portfolio consists of four integrated offerings: Accellacare Site Network (50+ owned and affiliate research sites across the US, UK, Spain, and India), Accellacare In-Home Services (decentralized home-based trial visits across 60+ countries), Accellacare Site Resourcing (staffing support with access to 77k+ candidates), and Patient Voice (patient engagement program).
Is Accellacare a public or private company?
Accellacare is a private company. It is classified as corporate owned and is currently operating.
When was Accellacare founded?
Accellacare was founded in 2020. It employs 501 to 1,000 people.
Where is Accellacare based?
Accellacare is headquartered in Winston Salem, United States, in the North America region.
How does Accellacare make money?
Three revenue lines are on record. Site Network Services are the primary driver. The others are in-Home Clinical Services and site Resourcing.
Who are Accellacare's main competitors?
Direct peers on record are PPD (Thermo Fisher Scientific), Fortrea (formerly Labcorp Drug Development), Parexel International, Worldwide Clinical Trials, Medpace and Syneos Health. Emerging players are ObvioHealth, Science 37 and Celerion. IQVIA is listed as a broad incumbent.
Does Accellacare have an API?
No public API is recorded for Accellacare.
What industry is Accellacare in?
Accellacare's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 621 and its SIC code is 8093.